Package 75834-209-15

Brand: tizanidine hydrochloride

Generic: tizanidine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 75834-209-15
Digits Only 7583420915
Product NDC 75834-209
Product ID 75834-209_359eaf8b-a8f7-4493-ba61-98e106bcc3d5
Description

150 CAPSULE in 1 BOTTLE (75834-209-15)

Marketing

Marketing Status
Marketed Since 2019-09-26
Brand tizanidine hydrochloride
Generic tizanidine hydrochloride
Sample Package No

Linked Drug Pages (1)

TIZANIDINE HYDROCHLORIDE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "359eaf8b-a8f7-4493-ba61-98e106bcc3d5", "openfda": {"upc": ["0375834208152", "0375834209159"], "unii": ["B53E3NMY5C"], "rxcui": ["485484", "485485", "485486"], "spl_set_id": ["c4a5b305-4265-4f90-a9ff-c16c0b936a06"], "manufacturer_name": ["Nivagen Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "150 CAPSULE in 1 BOTTLE (75834-209-15)", "package_ndc": "75834-209-15", "marketing_start_date": "20190926"}], "brand_name": "TIZANIDINE HYDROCHLORIDE", "product_id": "75834-209_359eaf8b-a8f7-4493-ba61-98e106bcc3d5", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "75834-209", "generic_name": "TIZANIDINE HYDROCHLORIDE", "labeler_name": "Nivagen Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TIZANIDINE HYDROCHLORIDE", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "6 mg/1"}], "application_number": "ANDA210021", "marketing_category": "ANDA", "marketing_start_date": "20190926", "listing_expiration_date": "20261231"}